Bulk Manufacturer of Controlled Substances Registration, 14913 [2017-05727]

Download as PDF 14913 Federal Register / Vol. 82, No. 55 / Thursday, March 23, 2017 / Notices INTERNATIONAL TRADE COMMISSION [USITC SE–17–012] Government in the Sunshine Act Meeting Notice United States International Trade Commission. TIME AND DATE: March 30, 2017 at 11:00 a.m. PLACE: Room 101, 500 E Street SW., Washington, DC 20436, Telephone: (202) 205–2000. STATUS: Open to the public. AGENCY HOLDING THE MEETING: Matters To Be Considered 1. Agendas for future meetings: None. 2. Minutes. 3. Ratification List. 4. Vote in Inv. No. 731–TA–1314 (Final) (Phosphor Copper from Korea). The Commission is currently scheduled to complete and file its determination and views of the Commission by April 17, 2017. 5. Outstanding action jackets: None. In accordance with Commission policy, subject matter listed above, not disposed of at the scheduled meeting, may be carried over to the agenda of the following meeting. By order of the Commission. Issued: March 21, 2017. William R. Bishop, Supervisory Hearings and Information Officer. [FR Doc. 2017–05893 Filed 3–21–17; 4:15 pm] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Registration ACTION: Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of controlled substances. SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as manufacturers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted for these notices. SUMMARY: Company FR docket sradovich on DSK3GMQ082PROD with NOTICES Noramco, Inc ................................................................................................................................................. Isosciences .................................................................................................................................................... AMRI Rensselaer, Inc ................................................................................................................................... Halo Pharmaceutical, Inc .............................................................................................................................. AMPAC Fine Chemicals LLC ........................................................................................................................ Insys Manufacturing LLC .............................................................................................................................. Patheon API Manufacturing, Inc ................................................................................................................... Euticals Inc .................................................................................................................................................... Nanosyn, Inc ................................................................................................................................................. Cerilliant Corporation ..................................................................................................................................... Research Triangle Institute ........................................................................................................................... Synthcon LLC ................................................................................................................................................ Navinta LLC ................................................................................................................................................... Johnson Matthey, Inc .................................................................................................................................... AMRI Rensselaer, Inc ................................................................................................................................... Cayman Chemical Company ........................................................................................................................ Cambridge Isotope Laboratories ................................................................................................................... Janssen Pharmaceutical, Inc ........................................................................................................................ The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR VerDate Sep<11>2014 17:13 Mar 22, 2017 Jkt 241001 Notice of registration. 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed persons. 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 FR FR FR FR FR FR FR FR FR FR FR FR FR FR FR FR FR FR 57936 61249 61250 63220 63222 63221 64509 64510 64949 66079 91948 95641 95640 95647 95639 95644 95644 96045 Published August 24, 2016. September 6, 2016. September 6, 2016. September 14, 2016. September 14, 2016. September 14, 2016. September 20, 2016. September 20, 2016. September 21, 2016. September 26, 2016. December 19, 2016. December 28, 2016. December 28, 2016. December 28, 2016. December 28, 2016. December 28, 2016. December 28, 2016. December 29, 2016. Dated: March 17, 2017. Louis J. Milione, Assistant Administrator. Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances. [FR Doc. 2017–05727 Filed 3–22–17; 8:45 am] SUPPLEMENTARY INFORMATION: BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Registration ACTION: PO 00000 SUMMARY: The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. Notice of registration. Frm 00049 Fmt 4703 Sfmt 4703 E:\FR\FM\23MRN1.SGM 23MRN1

Agencies

[Federal Register Volume 82, Number 55 (Thursday, March 23, 2017)]
[Notices]
[Page 14913]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05727]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as bulk 
manufacturers of various classes of controlled substances.

SUPPLEMENTARY INFORMATION: 
    The companies listed below applied to be registered as 
manufacturers of various basic classes of controlled substances. 
Information on previously published notices is listed in the table 
below. No comments or objections were submitted for these notices.

----------------------------------------------------------------------------------------------------------------
                 Company                             FR docket                           Published
----------------------------------------------------------------------------------------------------------------
Noramco, Inc.............................  81 FR 57936                    August 24, 2016.
Isosciences..............................  81 FR 61249                    September 6, 2016.
AMRI Rensselaer, Inc.....................  81 FR 61250                    September 6, 2016.
Halo Pharmaceutical, Inc.................  81 FR 63220                    September 14, 2016.
AMPAC Fine Chemicals LLC.................  81 FR 63222                    September 14, 2016.
Insys Manufacturing LLC..................  81 FR 63221                    September 14, 2016.
Patheon API Manufacturing, Inc...........  81 FR 64509                    September 20, 2016.
Euticals Inc.............................  81 FR 64510                    September 20, 2016.
Nanosyn, Inc.............................  81 FR 64949                    September 21, 2016.
Cerilliant Corporation...................  81 FR 66079                    September 26, 2016.
Research Triangle Institute..............  81 FR 91948                    December 19, 2016.
Synthcon LLC.............................  81 FR 95641                    December 28, 2016.
Navinta LLC..............................  81 FR 95640                    December 28, 2016.
Johnson Matthey, Inc.....................  81 FR 95647                    December 28, 2016.
AMRI Rensselaer, Inc.....................  81 FR 95639                    December 28, 2016.
Cayman Chemical Company..................  81 FR 95644                    December 28, 2016.
Cambridge Isotope Laboratories...........  81 FR 95644                    December 28, 2016.
Janssen Pharmaceutical, Inc..............  81 FR 96045                    December 29, 2016.
----------------------------------------------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of these registrants to manufacture 
the applicable basic classes of controlled substances is consistent 
with the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated each of the company's maintenance of 
effective controls against diversion by inspecting and testing each 
company's physical security systems, verifying each company's 
compliance with state and local laws, and reviewing each company's 
background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer 
to the above listed persons.

    Dated: March 17, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017-05727 Filed 3-22-17; 8:45 am]
 BILLING CODE 4410-09-P